We sought to apply iFRET to directly quantify PD-1/PD-L1 and CTLA-4/CD80 interactions in a cohort of patients in both their pre- and post-RFA-treated lung metastases, and iFRET results were correlated with the quantification of tumor-infiltrating lymphocytes. Here, CD80 is linked to neoplasm.